|
1
|
Brouwer‐Visser J, Fiaschi N, Deering RP, Dhanik A, Cygan KJ, Zhang W, Jeong S, Pourpe S, Boucher L, Hamon S, Topp MS, Bannerji R, Duell J, Advani RH, Flink DM, Chaudhry A, Sirulnik A, Lowy I, Murphy AJ, Weinreich DM, Yancopoulos GD, Thurston G, Ambati SR, Jankovic V. CLINICAL RESPONSES TO ODRONEXTAMAB (REGN1979): CORRELATION WITH LOSS OF CD20 EXPRESSION AS A POTENTIAL MECHANISM OF RESISTANCE AND BASELINE BIOMARKERS OF TUMOR T CELLS. Hematol Oncol 2021. [DOI: 10.1002/hon.6_2880] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- J Brouwer‐Visser
- Regeneron Pharmaceuticals, Inc Precision Medicine Tarrytown New York USA
| | - N Fiaschi
- Regeneron Pharmaceuticals, Inc Oncology and Angiogenesis Tarrytown New York USA
| | - R. P Deering
- Regeneron Pharmaceuticals, Inc Oncology and Angiogenesis Tarrytown New York USA
| | - A Dhanik
- Regeneron Pharmaceuticals, Inc VI Next Tarrytown New York USA
| | - K. J Cygan
- Regeneron Pharmaceuticals, Inc VI Next Tarrytown New York USA
| | - W Zhang
- Regeneron Pharmaceuticals, Inc Molecular Profiling and Data Science Tarrytown New York USA
| | - S Jeong
- Regeneron Pharmaceuticals, Inc Oncology and Angiogenesis Tarrytown New York USA
| | - S Pourpe
- Regeneron Pharmaceuticals, Inc Oncology and Angiogenesis Tarrytown New York USA
| | - L Boucher
- Regeneron Pharmaceuticals, Inc Oncology and Angiogenesis Tarrytown New York USA
| | - S Hamon
- Regeneron Pharmaceuticals, Inc Precision Medicine Tarrytown New York USA
| | | | - R Bannerji
- Rutgers Cancer Institute of New Jersey Division of Blood Disorders New Brunswick New Jersey USA
| | - J Duell
- Universitätsklinikum Würzburg Department of Internal Medicine 2 Würzburg Germany
| | - R. H Advani
- Stanford University Department of Medicine Stanford California USA
| | - D. M Flink
- Regeneron Pharmaceuticals, Inc Global Development Tarrytown New York USA
| | - A Chaudhry
- Regeneron Pharmaceuticals, Inc Hematology Tarrytown New York USA
| | - A Sirulnik
- Regeneron Pharmaceuticals, Inc Global Clinical Development Tarrytown New York USA
| | - I Lowy
- Regeneron Pharmaceuticals, Inc Translation Science and Oncology Tarrytown New York USA
| | - A. J Murphy
- Regeneron Pharmaceuticals, Inc Research Tarrytown New York USA
| | - D. M Weinreich
- Regeneron Pharmaceuticals, Inc Head of Global Clinical Development Tarrytown New York USA
| | - G. D Yancopoulos
- Regeneron Pharmaceuticals, Inc Chief Scientific Officer Tarrytown New York USA
| | - G Thurston
- Regeneron Pharmaceuticals, Inc Oncology Research Tarrytown New York USA
| | - S. R Ambati
- Regeneron Pharmaceuticals, Inc Clinical Sciences Hematology Tarrytown New York USA
| | - V Jankovic
- Regeneron Pharmaceuticals, Inc Precision Medicine Tarrytown New York USA
| |
Collapse
|